Nano-enabled photosynthesis in tumours to activate lipid peroxidation for overcoming cancer resistances
出版年份 2022 全文链接
标题
Nano-enabled photosynthesis in tumours to activate lipid peroxidation for overcoming cancer resistances
作者
关键词
Ferroptosis, Tumour microenvironment, Radiation, Hyperoxia, Nanotechnology, Cancer resistance
出版物
BIOMATERIALS
Volume 285, Issue -, Pages 121561
出版商
Elsevier BV
发表日期
2022-05-03
DOI
10.1016/j.biomaterials.2022.121561
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Radiation-Induced Lipid Peroxidation Triggers Ferroptosis and Synergizes with Ferroptosis Inducers
- (2020) Ling F. Ye et al. ACS Chemical Biology
- Engineering Corona Structure on Gold Nanoclusters for Gastrointestinal Imaging by Red‐shifted Emissions in the Second Near‐infrared Window
- (2020) Ruibin Li et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Metabolic determinants of cancer cell sensitivity to canonical ferroptosis inducers
- (2020) Mariluz Soula et al. Nature Chemical Biology
- Vacancies on 2D transition metal dichalcogenides elicit ferroptotic cell death
- (2020) Shujuan Xu et al. Nature Communications
- Porous platinum nanoparticles as a high-Z and oxygen generating nanozyme for enhanced radiotherapy in vivo
- (2019) Yan Li et al. BIOMATERIALS
- Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
- (2019) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Engineered Graphene Oxide Nanocomposite Capable of Preventing the Evolution of Antimicrobial Resistance
- (2019) Huizhen Zheng et al. ACS Nano
- Role of hypoxia in cancer therapy by regulating the tumor microenvironment
- (2019) Xinming Jing et al. Molecular Cancer
- Exploring the interactions between engineered nanomaterials and immune cells at 3D nano-bio interfaces to discover potent nano-adjuvants
- (2019) Ronglin Ma et al. Nanomedicine-Nanotechnology Biology and Medicine
- FSP1 is a glutathione-independent ferroptosis suppressor
- (2019) Sebastian Doll et al. NATURE
- Two-Dimensional Tin Selenide (SnSe) Nanosheets Capable of Mimicking Key Dehydrogenases in Cellular Metabolism
- (2019) Meng Gao et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Melanoma
- (2018) Dirk Schadendorf et al. LANCET
- Two-stage oxygen delivery for enhanced radiotherapy by perfluorocarbon nanoparticles
- (2018) Zaigang Zhou et al. Theranostics
- Oncogenic PI3K/AKT promotes the step-wise evolution of combination BRAF/MEK inhibitor resistance in melanoma
- (2018) Mal Irvine et al. Oncogenesis
- Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma
- (2018) Christian U. Blank et al. NATURE MEDICINE
- Multi-hierarchical profiling the structure-activity relationships of engineered nanomaterials at nano-bio interfaces
- (2018) Xiaoming Cai et al. Nature Communications
- Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition
- (2017) Matthew J. Hangauer et al. NATURE
- miR-25/93 mediates hypoxia-induced immunosuppression by repressing cGAS
- (2017) Min-Zu Wu et al. NATURE CELL BIOLOGY
- Radiotherapy and immunotherapy: a beneficial liaison?
- (2017) Ralph R. Weichselbaum et al. Nature Reviews Clinical Oncology
- Hollow MnO2 as a tumor-microenvironment-responsive biodegradable nano-platform for combination therapy favoring antitumor immune responses
- (2017) Guangbao Yang et al. Nature Communications
- Factors predictive of response, disease progression, and overall survival after dabrafenib and trametinib combination treatment: a pooled analysis of individual patient data from randomised trials
- (2016) Georgina V Long et al. LANCET ONCOLOGY
- Overcoming MITF-conferred drug resistance through dual AURKA/MAPK targeting in human melanoma cells
- (2016) G Pathria et al. Cell Death & Disease
- 12/15-lipoxygenase–mediated enzymatic lipid oxidation regulates DC maturation and function
- (2015) Tobias Rothe et al. JOURNAL OF CLINICAL INVESTIGATION
- Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunological mechanisms of the antitumor effects of supplemental oxygenation
- (2015) Stephen M. Hatfield et al. Science Translational Medicine
- Combined Vemurafenib and Cobimetinib in BRAF-Mutated Melanoma
- (2014) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Increased MAPK reactivation in early resistance to dabrafenib/trametinib combination therapy of BRAF-mutant metastatic melanoma
- (2014) Georgina V. Long et al. Nature Communications
- A Mechanism of Hypoxia-Mediated Escape from Adaptive Immunity in Cancer Cells
- (2013) I. B. Barsoum et al. CANCER RESEARCH
- Rare-earth-doped biological composites as in vivo shortwave infrared reporters
- (2013) D. J. Naczynski et al. Nature Communications
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
- (2012) Scott J. Dixon et al. CELL
- A Landscape of Driver Mutations in Melanoma
- (2012) Eran Hodis et al. CELL
- Distinguishing Clinicopathologic Features of Patients with V600E and V600K BRAF-Mutant Metastatic Melanoma
- (2012) A. M. Menzies et al. CLINICAL CANCER RESEARCH
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
- (2010) Gideon Bollag et al. NATURE
- Quantitative assays for esterified oxylipins generated by immune cells
- (2010) Alwena H Morgan et al. Nature Protocols
- Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
- (2010) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started